stars 1 stars 2 stars 3

Jazz Pharmaceuticals plc (Nasdaq: JAZZ), is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are focused on developing life-changing medicines for people with rare diseases—often with limited or no options—so they can live their lives more fully. By transforming biopharmaceutical discoveries into novel medicines, we are working to give people around the world the opportunity to redefine what’s possible – to make the “small wins” big again. Founded in 2003, we maintain a highly collaborative culture where employees focus on how they can be successful and accomplish positive results by exemplifying the company’s core values: integrity, collaboration, passion, innovation and the pursuit of excellence. Together, we are experts, analysts, specialists, advocates, scientists and professionals all with diverse backgrounds and perspectives. Working together, we are proud to support patients, innovate and bring new medicines to patients with critical unmet needs in rare disease. Please see our website at www.jazzpharma.com for more information. For information on recruitment, please visit https://careers.jazzpharma.com/. For guidelines on engaging with Jazz on social media, please visit https://bit.ly/2OaMOuq.

Website http://www.jazzpharma.com
Revenue $3.9 billion
Employees 3,672 (2,726 on RocketReach)
Founded 2003
Phone +1 604-708-5858
Technologies
Industry Pharmaceutical Manufacturing, Pharmaceuticals, Cataplexy, narcolepsy, Other Pharmaceuticals and Biotechnology, Oncology/Leukemia, Chronic Pain, Non-Opioid, Schizophrenia
Web Rank 842476
Keywords Biopharmaceutical, Medicine, Pharmaceutical, Drugs, Global Health, Oncology, Neurology, Sleep Medicine, Hematology, Immunology, Patient Care, Clinical Trials, Drug Development, Biotechnology, Prescription Drugs, Health Care, Therapeutics
Competitors Lilly India, Pfizer, Bristol Myers Squibb, Genentech, Amgen, Gilead Sciences, AstraZeneca, Roche, Sanofi, Novartis +46 more (view full list)

Jazz Pharmaceuticals Questions

The Jazz Pharmaceuticals annual revenue was $3.9 billion in 2026.

Declan Kelly is the Vice President, Head of Global Quality of Jazz Pharmaceuticals.

2,726 people are employed at Jazz Pharmaceuticals.

Top Jazz Pharmaceuticals Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users